ASCP H study materials
ASCP H study resources

A Silver Stain Where the Control Is Beautiful and the Patient Is Not

ASCP H · Put your knowledge to work in context.

All case studies

A Silver Stain Where the Control Is Beautiful and the Patient Is Not

A renal core biopsy for suspected membranous nephropathy is cut at 2 micrometers, floated on a 42 C water bath, and picked up on a charged slide. The Jones methenamine silver run, performed in a Coplin jar in a 60 C oven, includes a positive control (autopsy kidney) cut at 4 micrometers from a different block on an uncharged slide. The control shows crisp black glomerular and tubular basement membranes; the patient's glomeruli show grey-tan, poorly defined basement membranes. Both slides were incubated in the same jar for the same 60 minutes and counterstained together. An H&E section from the same patient block, cut at 4 micrometers, shows well-defined glomeruli.

1. Is this run valid? Reason from control logic rather than from the appearance of the control.

Read the worked answer

The run is not interpretable for the patient slide, even though the control is excellent.

The control answers one question: were the reagents and the incubation conditions capable of producing black basement membranes? It says yes. But the control differs from the patient section in at least three variables that matter:

  • Section thickness - 4 vs 2 micrometers.
  • Block - different tissue, different fixation and processing history.
  • Slide surface - uncharged vs charged.

A control validates only what it shares with the test section. Here the one variable most likely to drive silver intensity - thickness - is deliberately different, so the control cannot certify the patient's result.

Interpretive consequence: grey-tan basement membranes cannot be read as "no spikes" or as a negative for membranous nephropathy. The correct statement is that the stain is inadequate for diagnosis. Reporting it as negative would be a false negative on a treatable disease.

2. Give the two most likely explanations for grey-tan basement membranes in this specific setup, and how you would test each.

Read the worked answer

1. Section thickness (most likely). Methenamine silver deposits on the carbohydrate-rich basement membrane matrix; a 2-micrometer section presents roughly half the matrix of a 4-micrometer section, and thin sections also tend to show weaker, flatter staining and more background from the charged surface. Test: cut the patient block at 4 micrometers and repeat the identical run with the control also at 4 micrometers. If the membranes blacken, thickness was the cause.

2. Insufficient silver incubation for this block. The 60-minute incubation was tuned for a block that stains easily; a densely collagenized or differently fixed block may need longer. Test: include the patient's own tubular basement membranes as an on-slide internal control and extend incubation in 5-minute increments, checking microscopically. Stop when tubular membranes are crisp black - this is exactly what the internal control is for.

Less likely but worth excluding: contamination of the water bath with protein, an over-used silver solution at the end of its capacity, or an unusually old block. Each would be expected to affect the control too, which argues against them.

3. What is your decision tree before you report "inadequate for evaluation," and what would you tell the pathologist?

Read the worked answer

Decision tree:

  1. Re-cut at 4 micrometers and repeat with the control cut at the same thickness. Most cases resolve here.
  2. Add an on-slide internal control - the patient's own tubules - so intensity can be judged within the same section and the same thickness.
  3. Titrate incubation time against that internal control rather than against the separate control slide.
  4. If still grey: check the block's history (fixative, age, prior decalcification - a decalcified renal core will never silver properly), consider a different silver method, and consider whether the clinical question can be answered on H&E, trichrome, or a phospholipase A2 receptor immunostain.
  5. Only then report as inadequate, with a comment stating what was attempted.

To the pathologist: state plainly that the first run is not interpretable because the control did not match the test section in thickness, that a repeat is in progress, and that no conclusion about basement membrane spikes should be drawn from the current slide. Do not let a beautiful control slide create false confidence - the control's job is to fail when the method fails, and here it was set up so that it could not fail.